Homemade Versus Commercialized Single-access Port Devices in Single-incision Laparoscopic Appendectomy

September 1, 2022 updated by: National Taiwan University Hospital

Comparison of Homemade Versus Commercialized Single-access Port Devices for Single-incision Laparoscopic Appendectomy: A Retrospective Comparative Study

Homemade and commercialized single-assess port devices are two kinds of port devices commonly used for single-incision laparoscopic appendectomy. This study aimed to compare these two port devices in terms of short-term surgical outcomes and medical costs.

Study Overview

Detailed Description

The advantages of homemade port devices include accessibility of the composites and lower equipment costs to the patients; however, the potential disadvantage is the easy leakage of CO2, ballooning of the surgical glove, and device instability, leading to difficult maneuverability. On the other hand, commercialized port devices have relatively easy maneuverability, flexibility for instrument changes, and port stability for long-duration surgery ; however, their higher equipment cost is a disadvantage.

Study Type

Observational

Enrollment (Actual)

161

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Acute appendicitis patients

Description

Inclusion Criteria:

  • The patients were diagnosed as acute appendicitis and undergoing single-incision laparoscopic appendectomy

Exclusion Criteria:

  • The patient was not diagnosed as acute appendicitis based on surgical finding or pathological findings
  • The patients underwent surgery other than single-incision laparoscopic surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Handmade single-access port device
The homemade single-access device was composed of a wound protector, sterile surgical glove, and three trocars inserted into and secured over three digits of the glove
Commercialized single-access port devices
Commercialized single-access port devices including GelPOINT® (Applied Medical, Rancho Santa Margarita, CA, USA) and LAGIPORT® (LAGIS, Taichung, Taiwan)
Two kinds of commercialized single-access port devices were used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total surgical complications
Time Frame: Complications happened within 30 days
Complications were defined by Clavien-Dindo classification and comprehensive complication index.
Complications happened within 30 days
Superficial incisional surgical site infection (SSI)
Time Frame: Complications happened within 30 days
SSI was defined according to the American Centers for Disease Control and Prevention (CDC) classification
Complications happened within 30 days
Deep/organ SSI
Time Frame: Complications happened within 30 days
SSI was defined according to the American Centers for Disease Control and Prevention (CDC) classification
Complications happened within 30 days
Postoperative ileus
Time Frame: Complications happened within 30 days
Postoperative ileus was defined as the presence of symptoms and signs of abdominal distention, nausea, or vomiting combined with abdominal radiography, such as plain radiography or CT, within 30 days after SILA.
Complications happened within 30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical time
Time Frame: Time from skin incision to application of gauzes
Total time needed for completing surgery
Time from skin incision to application of gauzes
Time to resume soft diet
Time Frame: The time to resume a soft diet was measured as the duration between the time leaving the recovery room and the time to resume a soft diet recorded in the nursing note.
Total time needed to resume bowel ability to resuming soft diet
The time to resume a soft diet was measured as the duration between the time leaving the recovery room and the time to resume a soft diet recorded in the nursing note.
Postoperative length of hospitalization
Time Frame: Postoperative LOH was defined as the duration between leaving the recovery room and discharge.
Total time to stay in hospital
Postoperative LOH was defined as the duration between leaving the recovery room and discharge.
Total medical costs
Time Frame: From the time patient being brought to emergency room to the time patient being discharged
Medical costs were defined as the medical fees paid by the National Health Insurance and did not include the self-paid equipment fees needed in SILA (e.g., commercialized single-access port devices, or wound protector).
From the time patient being brought to emergency room to the time patient being discharged

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yu-Tso LIAO, MD, NTUH, Hsin-Chu Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2013

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

April 30, 2022

Study Registration Dates

First Submitted

August 31, 2022

First Submitted That Met QC Criteria

September 1, 2022

First Posted (Actual)

September 6, 2022

Study Record Updates

Last Update Posted (Actual)

September 6, 2022

Last Update Submitted That Met QC Criteria

September 1, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202104032RINB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Minimally Invasive Surgical Procedures

Clinical Trials on Commercialized single-access port devices

3
Subscribe